A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies

BACKGROUND: Phosphatase of regenerating liver-3 (PRL-3) is involved in cellular processes driving metastasis, cell proliferation, invasion, motility and survival. It has been shown to be upregulated and overexpressed in cancer tissue, in contrast to low or no expression in most normal tissue. PRL3-z...

Descripción completa

Detalles Bibliográficos
Autores principales: Chee, Cheng E., Ooi, Melissa, Lee, Soo-Chin, Sundar, Raghav, Heong, Valerie, Yong, Wei-Peng, Ng, Chin Hin, Wong, Andrea, Lim, Joline S. J., Tan, David S. P., Soo, Ross, Tan, Joshua T. C., Yang, Song, Thura, Min, Al-Aidaroos, Abdul Qader, Chng, Wee Joo, Zeng, Qi, Goh, Boon-Cher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192144/
https://www.ncbi.nlm.nih.gov/pubmed/37060431
http://dx.doi.org/10.1007/s11523-023-00962-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192144/
https://www.ncbi.nlm.nih.gov/pubmed/37060431
http://dx.doi.org/10.1007/s11523-023-00962-w

Ejemplares similares